... to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis in PLoS Medicine. Scientists describe a unique combination of blood proteins that ...
Patients with idiopathic pulmonary fibrosis (IPF) may have a new treatment option, according to researchers in Japan. In a Phase III, double-blind, placebo-controlled clinical trial, the investigators ...
There may be a new way to predict mortality in patients with idiopathic pulmonary fibrosis, a devastating disease that slowly petrifies the lungs. Most patients live only three years after diagnosis ...
... help doctors predict when patients with idiopathic pulmonary fibrosis (IPF) are becoming dangerously ill ... M.D., chief of Pitt's Division of Pulmonary, Allergy and Critical Care Medicine. "Our current ...
... to provide lung tissue for research might help doctors predict when patients with idiopathic pulmonary fibrosis are becoming dangerously ill and also could point the way to interventions that could ...
... breath.
There are five million people worldwide that are affected by this disease, according to the Pulmonary Fibrosis Foundation. In the United States there are over 100,000 patients with Pulmonary ...
... have discovered that targeting of a novel gene utilizing genetic and pharmacologic strategies was successful in treating pulmonary fibrosis in mice and will be developed for future testing in humans.
... comprehensive look at the many factors that may improve and extend the lives of patients with pulmonary fibrosis: from rehabilitation of the lungs to the development and testing of new medications to ...
... School of Medicine & Dentistry. "Cardiovascular and other diseases including diabetes, cancer, and pulmonary fibrosis all involve scarring, which affects the organs' ability to function. Another ...
... and survival of tumours. These compounds could serve as effective treatments for patients with solid tumours, breast cancer and ovarian cancer as well as pulmonary fibrosis and neuropathic pain...
Hepatitis C virus (HCV) is one of the more common causes of chronic liver disease in world with a variety of extrahepatic complications such as essential mixed cryoglobulinemia, membranoproliferative ...
... . 1 issue of the American Journal of Respiratory and Critical Care Medicine.
Idiopathic pulmonary fibrosis is an incurable lung disease that affects approximately 50,000 people in the United States. ...
... fibrosis (IPF) are three times as likely to experience severe coronary events—including heart ... Improvement Network for 920 patients with idiopathic pulmonary fibrosis and 3,593 control subjects ...
... for human telomerase are also likely to compromise telomerase function and may thus contribute to diseases such as dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis."
... ,000 patients have IPF, and about 40,000 patients die from the disease each year, according to the Pulmonary Fibrosis Foundation. The disease typically strikes people in their 50s and older, causing ...
